H57.1
Conditions
Interventions
Group 1: In the planned clinical observational study, male and female patients undergoing enucleation, orbitotomy, corneal transplantation or other eye surgery will be examined.
Patients will receive
0=no pain
10=maximal pain) preoperatively and on all postoperative inpatient days. Quality of life is measured on postoperative day 3 using SF36 questionnaire (Short Form 36, psychometric questionnaire, see App
Sponsors
Universitätsklinikum KölnKlinik für Anästhesiologie und Operative Intensivemdizin
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients undergoing orbitotomy, enucleation of the eye, corneal transplantation or other eye surgery Minimum age 18 years Present, signed informed consent form Patient consent after detailed information about the study ASA classification I-III 50 - 120 kg body weight
Exclusion criteria
Exclusion criteria: Intolerance to ibuprofen, metamizole, tilidine, tramadol, oxycodone, or morphine Patients under 18 years of age Patients who have not signed a consent form Patients who could not be adequately informed due to language and comprehension problems. Patients who were not cleared for surgery after the premedication visit due to their pre-existing conditions released for surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of this observational study is pain severity reported on all postoperative days and at discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints are quality of life, (additional) analgesic consumption, adverse events, mortality, morbidity, and perioperative complications, e.g., wound healing disorders. | — |
Countries
Germany
Contacts
Public ContactNicolas Leister
Universitätsklinikum KölnKlinik für Anästhesiologie und Operative Intenisvmedizin
Outcome results
None listed